Beshear Ends Out-of-State Medical Marijuana Purchase Option
Kentucky governor closes interim purchasing pathway as in-state dispensaries prepare to open in 2027.

Close-up of cannabis plants growing in an outdoor greenhouse in Salinas, CA.
Interim Program Closed Ahead of In-State Rollout
Governor Andy Beshear terminated Kentucky's out-of-state medical marijuana purchase allowance effective June 12, 2026. The program, launched via executive order in late 2024, let Kentucky residents with qualifying conditions cross state lines and purchase medical cannabis in Illinois, Ohio, Michigan, Missouri, and West Virginia. Beshear's office confirmed the closure in a brief statement, citing progress on Kentucky's domestic licensing framework as the reason for ending the interim measure.
The out-of-state option was always a bridge. Kentucky's full medical marijuana law, Senate Bill 47, passed in March 2023 and mandates a regulated in-state market. Licensing for cultivators, processors, and dispensaries is underway. First retail locations should open in early 2027.
Why the Timing Matters
The cleanest read on the closure is operational readiness, not policy reversal. Kentucky's Office of Medical Cannabis issued its first provisional cultivation licenses in April 2026, and dispensary applications opened May 1. With 38 cultivation licenses awarded and 112 dispensary applications under review, state regulators signaled confidence that domestic supply will be online within eight months.
Three factors drove the decision:
- Licensing velocity: Kentucky awarded more cultivation licenses in its first round than Ohio did in its entire first year.
- Seed-to-sale tracking: The state's Metrc integration went live June 1, enabling real-time inventory oversight.
- Political optics: Extending the out-of-state program risked criticism that Kentucky was subsidizing Illinois and Ohio tax revenue instead of building its own market.
Patients who relied on the interim program now face a supply gap until Kentucky dispensaries open. No hardship extension. No compassionate-use workaround.
Impact on Patients and Border-State Markets
An estimated 4,200 Kentucky residents registered for out-of-state purchases between January 2025 and May 2026, according to state data. Illinois dispensaries near the Kentucky border reported Kentucky patients accounted for 8-12% of medical sales in the first quarter of 2026. That revenue stream ends immediately.
Kentucky patients now face three choices: wait for in-state dispensaries, relocate temporarily to a legal state, or operate in the unregulated market. Patient advocates criticized the abrupt cutoff. The Kentucky Cannabis Freedom Coalition called the move "premature" and urged Beshear to extend the program through December 2026 or until the first Kentucky dispensary opens, whichever comes first.
No extension has been offered. The governor's office stated that patients should "monitor licensing announcements" for updates on dispensary openings.
What's Next for Kentucky's Medical Program
Kentucky's Office of Medical Cannabis projects 15-20 dispensaries will be operational by March 2027, concentrated in Louisville, Lexington, and Northern Kentucky. The state's licensing framework caps dispensary licenses at 225 statewide, with priority scoring for minority-owned, veteran-owned, and rural applicants. Cultivation facilities must pass final inspections by December 2026 to meet the Q1 2027 retail timeline.
Next milestone: final dispensary license awards, expected in September 2026. Until then, Kentucky's 60,000+ registered medical marijuana patients have no legal in-state or out-of-state purchase option. For full background on this story, see the CannIntel topic hub on Kentucky's medical marijuana program.
We'll be watching three indicators: dispensary license approval velocity, cultivation facility inspection pass rates, and whether patient advocacy groups escalate legal challenges to the program closure.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Illinois Bans Intoxicating Hemp Sales to Minors Under New Law
Gov. Pritzker signed legislation prohibiting minor access to intoxicating hemp products and expanding cannabis equity oversight.

Virginia House Conferees Advance Budget With Cannabis Legalization
House budget conferees unveiled a spending proposal that includes legal cannabis sales and a new data center oversight commission.

Constitutional Challenge Threatens DEA Rescheduling Timeline
Legal scholars argue Controlled Substances Act framework may violate separation-of-powers doctrine, imperiling cannabis reform.
More from the newsroom

Slate Feature Challenges Millennial Cannabis Narrative Amid Health Warnings
Opinion piece highlights gap between legalization-era messaging and emerging research on long-term use risks.

Curaleaf Launches Premium Flower in Germany as Market Matures
U.S. MSO debuts Select Elite brand in German pharmacies, signaling shift from medical-only access to premium consumer positioning.

Pre-Flower vs Week One: What's Actually Happening Inside
The flip doesn't start flowering. Here's the hormonal cascade, metabolic shift, and structural changes between photoperiod switch and true week one.